|
注册号: Registration number: |
ChiCTR2400089194 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-03 16:34:44 |
|
注册时间: Date of Registration: |
2024-09-03 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于移动的应用程序在脑卒中居家康复患者中的有效性:一项随机对照试验 |
|
Public title: |
Mobile-based applications in stroke Effectiveness in home-based rehabilitation patients: a randomized controlled trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于移动的应用程序在脑卒中居家康复患者中的有效性:一项随机对照试验 |
|
Scientific title: |
Mobile-based applications in stroke Effectiveness in home-based rehabilitation patients: a randomized controlled trial |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘敏 |
研究负责人: |
刘敏 |
|
Applicant: |
Liu Min |
Study leader: |
Liu Min |
|
申请注册联系人电话: Applicant telephone: |
+86 135 1153 6339 |
研究负责人电话:
Study leader's |
+86 135 1153 6339 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
hayysjn3k@163.com |
研究负责人电子邮件: Study leader's E-mail: |
hayysjn3k@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省淮安市淮安区锦绣江南小区 |
研究负责人通讯地址: |
江苏省淮安市淮安区锦绣江南小区 |
|
Applicant address: |
Jiangsu Province Huai 'an district, Huai 'an city Jinxiujiangnan community |
Study leader's address: |
Jiangsu Province Huai 'an district, Huai 'an city Jinxiujiangnan community |
|
申请注册联系人邮政编码: Applicant postcode: |
223200 |
研究负责人邮政编码: Study leader's postcode: |
223200 |
|
申请人所在单位: |
南京医科大学附属淮安第一人民医院 |
||
|
Applicant's institution: |
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University |
||
|
研究负责人所在单位: |
南京医科大学附属淮安第一人民医院 |
||
|
Affiliation of the Leader: |
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KY-2024-027-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
淮安市第一人民医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Huai 'an First People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-03-15 00:00:00 | ||
|
伦理委员会联系人: |
王其龙 |
||
|
Contact Name of the ethic committee: |
Wang Qilong |
||
|
伦理委员会联系地址: |
江苏省淮安市淮阴区黄河西路1号 |
||
|
Contact Address of the ethic committee: |
1 Huanghe West Road, Huaiyin District, Huai 'an City, Jiangsu Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 158 6171 0352 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
南京医科大学附属淮安第一人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
南京医科大学附属淮安第一人民医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
There is no |
||||||||||||||||||||||
|
研究疾病: |
脑卒中 |
||||||||||||||||||||||
|
Target disease: |
stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究目的旨在评价脑卒中居家患者通过移动的应用程序提供康复计划的有效性 |
||||||||||||||||||||||
|
Objectives of Study: |
The aim of this study was to evaluate the effectiveness of a rehabilitation program delivered via a mobile app for home-based stroke survivors |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
①合并精神疾病或其他严重躯体疾病;②患者及家属不配合;③患者存在认知功能障碍;④涉及并参与其他研究者;⑤人工气道患者;⑥妊娠期患者;⑦合并吸入性肺炎、关节脱位、骨折等严重并发症。 |
||||||||||||||||||||||
|
Exclusion criteria: |
① complicated with mental illness or other serious physical diseases; ② Patients and their families did not cooperate; ③ The patient had cognitive dysfunction; ④ involving and participating in other researchers; ⑤ patients with artificial airway; ⑥ pregnant patients; ⑦ Severe complications such as aspiration pneumonia, joint dislocation and fracture were observed. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-04-01 00:00:00至 To 2024-04-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-04-02 00:00:00 至 To 2024-04-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
在获得患者的知情同意后,所有符合条件的参与者将被分为男性和女性,因为性别影响结肠镜检查患者的焦虑水平(9)。我们将使用区组大小可变的区组随机化,以1∶1的比例将参与者分配至干预组或对照组。各组的分配顺序将由计算机生成,随机分组将由一名计算机技术人员独立完成。为了隐藏分配结果,小组分配将被放在一个不透明的信封中,参与者分配将由不参与任何研究的独立研究员进行。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
After obtaining informed consent from the patients, all eligible participants will be categorized into males and females, as gender affects anxiety levels in colonoscopy patients(9). Participants will be assigned to either the intervention group or the control group in a 1:1 ratio using block randomization with variable block sizes. The allocation sequence of the groups will be generated by the computer, and the randomization will be carried out by a computer technician, independent of others. In order to conceal the results of the allocation, group allocations will be placed in an opaque envelope, and participant allocation will be carried out by an independent researcher who is not involved in any part of the study. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
由于心理教育干预所需要的条件,不可能对干预人员进行盲化。基线信息和临床访谈在随机分组前收集和进行。数据的管理将由工作人员进行盲化。对结果和得出的结论的统计分析也将采用盲法。试验结果将由独立的统计学家分析,结果将由研究团队解读。 |
|
Blinding: |
Due to the conditions required for psycho-educational interventions, it is not possible to blind the interventionists. Baseline information and clinical interviews are gathered and conducted prior to randomization. Management of the data will be done by the staff member being blinded. Statistical analysis of the results and resulting conclusions will also be blinded. The trial results will be analyzed by an independent statistician, and the results will be interpreted by the research team. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2024年6月1日,临床试验公共管理平台,http://www.medresman.org.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
June 1, 2024, ResMan, a public management platform for clinical trials, http://www.medresman.org.cn |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表和电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form and Electronic Data Capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |